| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 04/10/2012 | CA2414960C Epoxycarboxamide compound, azide compound, and amino alcohol compound, and process for preparing .alpha.keto amide compound using them |
| 04/05/2012 | WO2012041986A1 Process for the preparation of amino acid derivatives |
| 04/05/2012 | WO2012010651A3 Method for the preparation of omega-amino-alkaneamides and omega-amino-alkanethioamides as well as intermediates of this method |
| 04/05/2012 | US20120083625 Preparation of iodixanol |
| 04/05/2012 | US20120083440 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 04/04/2012 | CN102405209A Diacylethylenediamine compound |
| 04/04/2012 | CN102399167A Method for preparing 5-amino-N,N'-di(2,3-dihydroxypropyl)-2,4,6-triiodoisophthal amide |
| 04/04/2012 | CN102397765A 一种表面活性剂、其制备方法和所涉及的中间体及其应用 A surfactant, their preparation and intermediates involved in their application |
| 04/04/2012 | CN101921376B 具有识别能力的手性三组分聚合物及其制备和应用 Chiral three-component polymer and its preparation and application has the ability to identify |
| 04/03/2012 | US8148576 Solid state forms of aliskiren compounds |
| 04/03/2012 | CA2698441C Process for the manufacture of bridged monobactam intermediates |
| 04/03/2012 | CA2566464C Synthesis of tetracyclines and analogues thereof |
| 03/29/2012 | WO2012009678A8 Therapeutically active compositions and their method of use |
| 03/29/2012 | WO2011149213A3 Novel derivative having inhibitory activity against 11β-hsd1, preparation method thereof, and pharmaceutical composition containing same as active ingredient |
| 03/29/2012 | US20120073472 Reactive derivatives on the basis of dianhydrohexitol-based isocyanates |
| 03/28/2012 | CN102391148A Synthetic method for high-purity tigecycline |
| 03/28/2012 | CN101774986B Method for preparing aliskiren and intermediate thereof |
| 03/28/2012 | CN101575301B Preparation method of 2-amino-5-chlorobenzamide |
| 03/27/2012 | US8143242 Malonamide derivatives with antithrombotic activity |
| 03/27/2012 | CA2527141C Polyhydroxy phenols and their use in binding p-selectin |
| 03/22/2012 | WO2012035557A1 Novel cationic amphiphiles with mannose-mimicking head-groups and a process for the preparation thereof |
| 03/22/2012 | US20120071664 Beta-amino acids and methods and intermediates for making same |
| 03/22/2012 | US20120071528 Methods and compositions for treatment of diabetes and dyslipidemia |
| 03/21/2012 | EP2429991A1 Redox drug derivatives |
| 03/21/2012 | EP2188254B1 Novel bradykinin b1-antagonists |
| 03/21/2012 | EP2049493B1 Compounds suitable as modulators of hdl |
| 03/21/2012 | CN1984883B Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies |
| 03/21/2012 | CN102382076A Arone and arylamide compound and preparation method and medicine use thereof |
| 03/21/2012 | CN102382007A Doxycycline hydrochloride compound and preparation method thereof |
| 03/21/2012 | CN101781035B Method for recovering terramycin from terramycin production wastewater. |
| 03/21/2012 | CN101508656B Ion-exchange recovery method for synergistic matter in Bt fermentation |
| 03/21/2012 | CN101164543B Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 03/20/2012 | US8138218 Growth hormone secretagogues |
| 03/20/2012 | CA2672656C Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| 03/20/2012 | CA2444463C Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 03/20/2012 | CA2402719C Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 03/20/2012 | CA2363067C Compounds and methods to inhibit or augment an inflammatory response |
| 03/15/2012 | WO2012034065A1 Aliskiren intermediates and a process for analyzing the purity of aliskiren |
| 03/15/2012 | US20120065208 Cancer treatment |
| 03/15/2012 | US20120065138 Lipids, lipid complexes and use thereof |
| 03/14/2012 | EP2428566A1 Gene transfer agent composition containing polyamidoamine dendron |
| 03/14/2012 | EP2428503A1 Synthesis of tripodal catechol derivatives with a flexible base for functionalising surfaces |
| 03/14/2012 | EP2428502A1 Synthesis of tripodal catechol derivatives with an adamantyl base for functionalising surfaces |
| 03/14/2012 | EP2427426A1 Insecticidal compounds |
| 03/14/2012 | EP2427425A2 Tetracycline compounds |
| 03/14/2012 | EP2427196A1 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine |
| 03/14/2012 | EP2103601B1 Process for production of phenylalanine derivatives having quinazolinedione skeletons and intermediates for the production |
| 03/14/2012 | CN102378754A 3-aminoxalylaminobenzamide derivatives, and insecticidal and miticidal agents containing same as active ingredient |
| 03/14/2012 | CN102372713A Dual alanyl-aminopeptidase and dipeptidyl-peptidase iv inhibitors |
| 03/14/2012 | CN102372649A Diamine, liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display component |
| 03/13/2012 | US8133514 Carbon-substituted diketopiperazine delivery systems |
| 03/08/2012 | US20120059188 Halogenated analogues of anti-fibrotic agents |
| 03/07/2012 | EP2426104A1 Tigecycline crystalline form and process for preparation thereof |
| 03/07/2012 | EP2424842A2 Dual mechanism inhibitors for the treatment of disease |
| 03/07/2012 | EP2424834A2 Synthesis of tetracyclines and intermediates thereto |
| 03/06/2012 | US8129566 Polycationic compounds and uses thereof |
| 03/06/2012 | US8129545 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 03/06/2012 | US8129537 Compounds as PDE IV and TNF inhibitors |
| 03/06/2012 | US8129407 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 03/06/2012 | US8129355 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/01/2012 | US20120053346 Pyrimidine Carboxamide Derivatives |
| 03/01/2012 | US20120053233 Gene transfer agent composition containing polyamidoamine dendron |
| 02/29/2012 | EP1667966B1 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 02/29/2012 | CN102363600A Iomeprol preparation method |
| 02/23/2012 | US20120046492 Ethoxy Diphenyl Ethane Derivatives, Preparation Processes and Uses Thereof |
| 02/23/2012 | US20120046293 Renin inhibitors |
| 02/23/2012 | US20120046272 Novel Therapeutic Compounds |
| 02/22/2012 | EP0986384B1 Inhibitors of protein isoprenyl transferases |
| 02/22/2012 | CN102361850A process for isolating tigecycline |
| 02/22/2012 | CN102358725A Preparation method of intermediate of isoxazole compound |
| 02/22/2012 | CN102358721A More stable aceglutamide compound and medicinal composition thereof |
| 02/21/2012 | US8119841 Crystalline forms of aliskiren hemifumarate |
| 02/21/2012 | US8119627 Heterocyclic compounds as inhibitors of 17beta-HSD3 |
| 02/21/2012 | US8119622 7-phenyl-substituted tetracycline compounds |
| 02/21/2012 | CA2508618C Tetrahydro-naphthalene derivatives |
| 02/21/2012 | CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 02/16/2012 | WO2012021800A2 Caspase inhibitors as therapeutics for neural and organ injury and imaging |
| 02/16/2012 | WO2012021788A2 Dipeptide calpain inhibitors |
| 02/16/2012 | WO2012021446A2 Process for preparing aliskiren and its intermediates |
| 02/16/2012 | WO2011115687A3 Alkylated sp-b peptoid compounds and related lung surfactant compositions |
| 02/16/2012 | US20120041063 Antitumoral compounds |
| 02/16/2012 | US20120041039 Amine derivative compounds for treating ophthalmic diseases and disorders |
| 02/16/2012 | US20120041038 Amine derivative compounds for treating ophthalmic diseases and disorders |
| 02/16/2012 | US20120041036 Substituted acylguanidine derivatives (as amended) |
| 02/16/2012 | US20120039920 Hydrophobic monomers, hydrophobically-derivatized supports, and methods of making and using the same |
| 02/16/2012 | US20120039815 Contrast agents |
| 02/15/2012 | EP2418196A1 Dual alanyl-aminopeptidase and dipeptidyl-peptidase IV inhibitors |
| 02/15/2012 | EP1975149B1 1,3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof |
| 02/15/2012 | CN102351735A Preparation method of Iopromide |
| 02/15/2012 | CN102351734A Preparation method for aliskiren |
| 02/15/2012 | CN102351733A Method for preparing 2-amino-dimethyl acetamide hydrochloride |
| 02/15/2012 | CN101822841B 有机胺衍生物作为小分子药物脑靶向修饰基团的用途 Organic amine derivatives as small molecule drugs targeting the brain uses a modified group |
| 02/09/2012 | US20120035239 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 02/08/2012 | EP2414323A1 Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medical products |
| 02/08/2012 | EP2414321A2 Hydrophobic monomers, hydrophobically-derivatized supports, and methods of making and using the same |
| 02/08/2012 | EP2414320A1 A process for dimethylation of active methylene groups |
| 02/08/2012 | CN102344388A Polypropylene beta nucleating agent and its preparation method and use |
| 02/08/2012 | CN102344387A Method for producing free iodine by adding potassium iodide during iodine monochloride solution preparation process |
| 02/08/2012 | CN102344386A Decolouring contrast agent intermediate |
| 02/08/2012 | CN101148418B 一枝蒿酮酸衍生物及其用途 Rupestonic acid derivatives and their use |